- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Bafilomycin A1 (CAT#: Vinh-001SX)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-001SX |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- (-)-Bafilomycin A1, ATPase Inhibitor
- Target
- SARS-CoV-2
- Molecular Formula
- C35H58O9
- Molecular Weight
- 622.8 g/mol
- Purity
- >98% by HPLC
- Storage
- Store at -20°C.
- Introduction
- Bafilomycin A is a macrolide antibiotic and a highly potent V-ATPase inhibitor. It has been well researched for its role as an inhibitor of the vascular proton ATPases and has been administered to demonstrate the requirement of low endosomal pH for viral uncoating. Bafilomycin A has been actively studied for its role against viruses like influenza A and hepatitis C. Scientists are studying clinical implications of using Bafilomycin A1 against the SARS-CoV-2 virus as it has been documented that the Nsp6 and M proteins of SARS-CoV-2 interact with the V1-ATPase subunits.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.